Logo image of MAMA

MAMA'S CREATIONS INC (MAMA) Stock Fundamental Analysis

NASDAQ:MAMA - Nasdaq - US56146T1034 - Common Stock - Currency: USD

7.7  -0.18 (-2.28%)

After market: 7.7 0 (0%)

Fundamental Rating

5

Taking everything into account, MAMA scores 5 out of 10 in our fundamental rating. MAMA was compared to 91 industry peers in the Food Products industry. Both the profitability and the financial health of MAMA get a neutral evaluation. Nothing too spectacular is happening here. MAMA is valued quite expensive, but it does show an excellent growth. With these ratings, MAMA could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

MAMA had positive earnings in the past year.
MAMA had a positive operating cash flow in the past year.
Of the past 5 years MAMA 4 years were profitable.
MAMA had a positive operating cash flow in each of the past 5 years.
MAMA Yearly Net Income VS EBIT VS OCF VS FCFMAMA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

1.2 Ratios

The Return On Assets of MAMA (7.35%) is better than 76.74% of its industry peers.
The Return On Equity of MAMA (15.30%) is better than 80.23% of its industry peers.
With an excellent Return On Invested Capital value of 14.89%, MAMA belongs to the best of the industry, outperforming 93.02% of the companies in the same industry.
Industry RankSector Rank
ROA 7.35%
ROE 15.3%
ROIC 14.89%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MAMA Yearly ROA, ROE, ROICMAMA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400

1.3 Margins

MAMA's Profit Margin of 3.02% is in line compared to the rest of the industry. MAMA outperforms 50.00% of its industry peers.
In the last couple of years the Profit Margin of MAMA has grown nicely.
With a Operating Margin value of 4.22%, MAMA perfoms like the industry average, outperforming 52.33% of the companies in the same industry.
MAMA's Operating Margin has improved in the last couple of years.
The Gross Margin of MAMA (24.58%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of MAMA has declined.
Industry RankSector Rank
OM 4.22%
PM (TTM) 3.02%
GM 24.58%
OM growth 3Y0.27%
OM growth 5Y10.76%
PM growth 3Y-14.21%
PM growth 5Y31.88%
GM growth 3Y-1.33%
GM growth 5Y-3.71%
MAMA Yearly Profit, Operating, Gross MarginsMAMA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MAMA is still creating some value.
There is no outstanding debt for MAMA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MAMA Yearly Shares OutstandingMAMA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
MAMA Yearly Total Debt VS Total AssetsMAMA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

MAMA has an Altman-Z score of 9.78. This indicates that MAMA is financially healthy and has little risk of bankruptcy at the moment.
MAMA has a better Altman-Z score (9.78) than 94.19% of its industry peers.
MAMA has a debt to FCF ratio of 1.03. This is a very positive value and a sign of high solvency as it would only need 1.03 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.03, MAMA belongs to the top of the industry, outperforming 80.23% of the companies in the same industry.
A Debt/Equity ratio of 0.16 indicates that MAMA is not too dependend on debt financing.
The Debt to Equity ratio of MAMA (0.16) is better than 72.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 1.03
Altman-Z 9.78
ROIC/WACC1.62
WACC9.2%
MAMA Yearly LT Debt VS Equity VS FCFMAMA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

MAMA has a Current Ratio of 1.17. This is a normal value and indicates that MAMA is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.17, MAMA is not doing good in the industry: 68.60% of the companies in the same industry are doing better.
MAMA has a Quick Ratio of 1.17. This is a bad value and indicates that MAMA is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of MAMA (1.00) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1
MAMA Yearly Current Assets VS Current LiabilitesMAMA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

7

3. Growth

3.1 Past

MAMA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -50.00%.
The Earnings Per Share has been growing by 55.18% on average over the past years. This is a very strong growth
MAMA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.20%.
Measured over the past years, MAMA shows a very strong growth in Revenue. The Revenue has been growing by 29.40% on average per year.
EPS 1Y (TTM)-50%
EPS 3Y14.47%
EPS 5Y55.18%
EPS Q2Q%-80%
Revenue 1Y (TTM)17.2%
Revenue growth 3Y36.33%
Revenue growth 5Y29.4%
Sales Q2Q%10.04%

3.2 Future

Based on estimates for the next years, MAMA will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.23% on average per year.
The Revenue is expected to grow by 14.23% on average over the next years. This is quite good.
EPS Next Y-53.25%
EPS Next 2Y5.79%
EPS Next 3Y15.23%
EPS Next 5YN/A
Revenue Next Year18.96%
Revenue Next 2Y15.81%
Revenue Next 3Y14.23%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MAMA Yearly Revenue VS EstimatesMAMA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
MAMA Yearly EPS VS EstimatesMAMA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 0.2

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 85.56 indicates a quite expensive valuation of MAMA.
60.47% of the companies in the same industry are cheaper than MAMA, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 28.46. MAMA is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 38.22, the valuation of MAMA can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as MAMA.
MAMA is valuated cheaply when we compare the Price/Forward Earnings ratio to 92.56, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 85.56
Fwd PE 38.22
MAMA Price Earnings VS Forward Price EarningsMAMA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MAMA is valued a bit more expensive than 62.79% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as MAMA.
Industry RankSector Rank
P/FCF 37.89
EV/EBITDA 36.97
MAMA Per share dataMAMA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The decent profitability rating of MAMA may justify a higher PE ratio.
A more expensive valuation may be justified as MAMA's earnings are expected to grow with 15.23% in the coming years.
PEG (NY)N/A
PEG (5Y)1.55
EPS Next 2Y5.79%
EPS Next 3Y15.23%

0

5. Dividend

5.1 Amount

MAMA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MAMA'S CREATIONS INC

NASDAQ:MAMA (1/31/2025, 8:00:00 PM)

After market: 7.7 0 (0%)

7.7

-0.18 (-2.28%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)12-16 2024-12-16/amc
Earnings (Next)N/A N/A
Inst Owners62.33%
Inst Owner ChangeN/A
Ins Owners10.24%
Ins Owner Change-1.01%
Market Cap289.44M
Analysts82
Price Target11.73 (52.34%)
Short Float %5.84%
Short Ratio5.17
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-28.1%
Min EPS beat(2)-73.86%
Max EPS beat(2)17.65%
EPS beat(4)2
Avg EPS beat(4)-17.51%
Min EPS beat(4)-73.86%
Max EPS beat(4)42.6%
EPS beat(8)6
Avg EPS beat(8)46.43%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.85%
Min Revenue beat(2)-1.14%
Max Revenue beat(2)2.84%
Revenue beat(4)3
Avg Revenue beat(4)4.61%
Min Revenue beat(4)-1.14%
Max Revenue beat(4)11.95%
Revenue beat(8)7
Avg Revenue beat(8)3.5%
Revenue beat(12)10
Avg Revenue beat(12)4.44%
Revenue beat(16)12
Avg Revenue beat(16)1.76%
PT rev (1m)0%
PT rev (3m)4.55%
EPS NQ rev (1m)-47.83%
EPS NQ rev (3m)-42.86%
EPS NY rev (1m)-41.07%
EPS NY rev (3m)-41.07%
Revenue NQ rev (1m)-3.42%
Revenue NQ rev (3m)3.57%
Revenue NY rev (1m)0.32%
Revenue NY rev (3m)0.32%
Valuation
Industry RankSector Rank
PE 85.56
Fwd PE 38.22
P/S 2.49
P/FCF 37.89
P/OCF 22.65
P/B 12.59
P/tB 27.45
EV/EBITDA 36.97
EPS(TTM)0.09
EY1.17%
EPS(NY)0.2
Fwd EY2.62%
FCF(TTM)0.2
FCFY2.64%
OCF(TTM)0.34
OCFY4.41%
SpS3.1
BVpS0.61
TBVpS0.28
PEG (NY)N/A
PEG (5Y)1.55
Profitability
Industry RankSector Rank
ROA 7.35%
ROE 15.3%
ROCE 16.91%
ROIC 14.89%
ROICexc 21.92%
ROICexgc 59.37%
OM 4.22%
PM (TTM) 3.02%
GM 24.58%
FCFM 6.56%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y0.27%
OM growth 5Y10.76%
PM growth 3Y-14.21%
PM growth 5Y31.88%
GM growth 3Y-1.33%
GM growth 5Y-3.71%
F-Score5
Asset Turnover2.43
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 1.03
Debt/EBITDA 0.48
Cap/Depr 178.55%
Cap/Sales 4.41%
Interest Coverage 9.71
Cash Conversion 164.02%
Profit Quality 217.11%
Current Ratio 1.17
Quick Ratio 1
Altman-Z 9.78
F-Score5
WACC9.2%
ROIC/WACC1.62
Cap/Depr(3y)61.35%
Cap/Depr(5y)58.88%
Cap/Sales(3y)1.07%
Cap/Sales(5y)1.02%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50%
EPS 3Y14.47%
EPS 5Y55.18%
EPS Q2Q%-80%
EPS Next Y-53.25%
EPS Next 2Y5.79%
EPS Next 3Y15.23%
EPS Next 5YN/A
Revenue 1Y (TTM)17.2%
Revenue growth 3Y36.33%
Revenue growth 5Y29.4%
Sales Q2Q%10.04%
Revenue Next Year18.96%
Revenue Next 2Y15.81%
Revenue Next 3Y14.23%
Revenue Next 5YN/A
EBIT growth 1Y-44.28%
EBIT growth 3Y36.7%
EBIT growth 5Y43.32%
EBIT Next Year24.18%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y511.2%
FCF growth 3Y49.39%
FCF growth 5Y92.49%
OCF growth 1Y551.89%
OCF growth 3Y46.45%
OCF growth 5Y51.84%